Patient Satisfaction High for Mohs Micrographic Surgery

This article originally appeared here.
Share this content:
Patient Satisfaction High for Mohs Micrographic Surgery
Patient Satisfaction High for Mohs Micrographic Surgery

FRIDAY, July 15, 2016 (HealthDay News) -- For patients with skin cancer, Mohs micrographic surgery (MMS) is safe and well tolerated, with high levels of patient satisfaction, according to a research letter published online July 5 in the British Journal of Dermatology.

Walayat Hussain, M.B.Ch.B., from the Leeds Centre for Dermatology in the United Kingdom, and colleagues performed a prospective assessment of all cases treated with MMS over a three-month period to assess the safety, complication rate, and patient acceptance of MMS in the United Kingdom. Data were included for 565 patients with 565 tumors, of which 533 were basal cell carcinoma.

The researchers found that 88 percent of reconstructions were performed within the department on the day of admission. The mean number of stages was 1.3. There were no reports of major complications; four minor vasovagal intraoperative complications were reported. Postoperative complications included pain (five patients), bleeding (15 patients), infection (six patients), hematoma (one patient), and superficial flap necrosis (13 patients). Patient scores demonstrated low anxiety levels (3 of 10 on Likert scale), and high tolerance of surgery and satisfaction with surgery (9 and 10 of 10 on Likert scale, respectively).

"This review of MMS in the United Kingdom supports the fact that MMS and reconstruction performed under local anesthesia is safe, well tolerated, and associated with high levels of patient satisfaction," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

USPSTF Urges Abuse Screening for Reproductive-Aged Women

USPSTF Urges Abuse Screening for Reproductive-Aged Women

Evidence lacking for assessing balance of benefits, harms of screening for abuse of seniors, vulnerable

Five-Day Nitrofurantoin Beats Single-Dose Fosfomycin for UTI

Five-Day Nitrofurantoin Beats Single-Dose Fosfomycin for UTI

Increased likelihood of clinical and microbiological resolution for uncomplicated UTI in women

Exercise Intervention Doesn't Improve Walking Ability in PAD

Exercise Intervention Doesn't Improve Walking Ability in PAD

Smaller mean change from baseline to follow-up in 6-minute walking distance with exercise intervention

is free, fast, and customized just for you!

Already a member?

Sign In Now »